4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-24-132167
Chief Executive Officer sold 19,106 shares at $7.43 ($141,958)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Barrow Robert · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-26 | Sale : show line 1 in the form 10b5-1 | −19,106 | $7.43 | $141,958 | 526,666 | D |
| Open-market sales · 19,106 sh · avg $7.43 · $141,958 | ||||||
Loading xslF345X05/tm2432133-4_4seq1.xml…